Dataset for reporting of the invasive carcinoma of the breast: recommendations from the International Collaboration on Cancer Reporting (ICCR)

Author:

Ellis Ian1,Webster Fleur2ORCID,Allison Kimberly H3,Dang Chau4,Gobbi Helenice5,Kulka Janina6,Lakhani Sunil R7,Moriya Takuya8,Quinn Cecily M9ORCID,Sapino Anna1011,Schnitt Stuart12,Sibbering D Mark13,Slodkowska Elzbieta14,Yang Wentao15ORCID,Tan Puay H16ORCID

Affiliation:

1. Department of Histopathology Nottingham City Hospital London UK

2. International Collaboration on Cancer Reporting Surry Hills NSW Australia

3. Department of Pathology Stanford University School of Medicine Stanford CA USA

4. Memorial Sloan Kettering Cancer Center New York USA

5. Institute of Health Sciences, Federal University Triangulo Mineiro Uberaba Brazil

6. Department of Pathology, Forensic and Insurance Medicine Semmelweis University Budapest Hungary

7. Centre for Clinical Research and Pathology Queensland University of Queensland Brisbane Australia

8. Department of Pathology Kawasaki Medical School Okayama Japan

9. Department of Histopathology St. Vincent's University Hospital Dublin 4 Ireland

10. Department of Medical Sciences University of Turin Turin Italy

11. Candiolo Cancer Institute, FPO – IRCCS Candiolo Italy

12. Department of Pathology Brigham and Women's Hospital Boston MA USA

13. Department of Breast Surgery Royal Derby Hospital Derby UK

14. Department of Anatomic Pathology Sunnybrook Health Sciences Centre Toronto Ontario Canada

15. Department of Pathology Fudan University Shanghai Cancer Center Shanghai China

16. Luma Medical Centre, Royal Square Singapore Singapore

Abstract

Background and ObjectivesCurrent national or regional guidelines for the pathology reporting on invasive breast cancer differ in certain aspects, resulting in divergent reporting practice and a lack of comparability of data. Here we report on a new international dataset for the pathology reporting of resection specimens with invasive cancer of the breast. The dataset was produced under the auspices of the International Collaboration on Cancer Reporting (ICCR), a global alliance of major (inter‐)national pathology and cancer organizations.Methods and ResultsThe established ICCR process for dataset development was followed. An international expert panel consisting of breast pathologists, a surgeon, and an oncologist prepared a draft set of core and noncore data items based on a critical review and discussion of current evidence. Commentary was provided for each data item to explain the rationale for selecting it as a core or noncore element, its clinical relevance, and to highlight potential areas of disagreement or lack of evidence, in which case a consensus position was formulated. Following international public consultation, the document was finalized and ratified, and the dataset, which includes a synoptic reporting guide, was published on the ICCR website.ConclusionsThis first international dataset for invasive cancer of the breast is intended to promote high‐quality, standardized pathology reporting. Its widespread adoption will improve consistency of reporting, facilitate multidisciplinary communication, and enhance comparability of data, all of which will help to improve the management of invasive breast cancer patients.

Publisher

Wiley

Reference33 articles.

1. College of American Pathologists(2022).Protocol for the examination of resection specimens from patients with invasive carcinoma of the breast. Available at:https://documents.cap.org/protocols/Breast.Invasive_4.6.0.0.REL_CAPCP.pdf(Accessed 2nd April 2023).

2. Royal College of Pathologists of Australasia(2012).Invasive breast cancer structured reporting protocol.2nd ed.Available at:https://www.rcpa.edu.au/getattachment/9c857cb6‐6878-4004‐bf8a‐37761873cf13/Protocol‐invasive‐breast‐cancer.aspx(Accessed 26th March 2023).

3. Royal College of Pathologists and National Coordinating Committee for Breast Pathology(2016).Pathology reporting of breast disease in surgical excision specimens incorporating the dataset for histological reporting of breast cancer. Available at:https://www.rcpath.org/profession/guidelines/cancer‐datasets-and‐tissue‐pathways.html(Accessed 26th March 2023).

4. Extending an evidence hierarchy to include topics other than treatment: revising the Australian 'levels of evidence'

5. International Collaboration on Cancer Reporting(2021).Ductal carcinoma In situ variants of lobular carcinomain situand low grade lesions histopathology reporting guide.1st ed.Available at:http://www.iccr‐cancer.org/datasets/published-datasets/breast(Accessed 20th June 2023).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3